Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Rev. Soc. Bras. Med. Trop ; 49(2): 196-203, Mar.-Apr. 2016. tab, graf
Artigo em Inglês | LILACS | ID: lil-782098

RESUMO

Abstract: INTRODUCTION: Leishmaniasis is a disease caused by the protozoan Leishmania that resides mainly in mononuclear phagocytic system tissues. Pentavalent antimonials are the main treatment option, although these drugs have toxic side effects and high resistance rates. A potentially alternative and more effective therapeutic strategy is to use liposomes as carriers of the antileishmanial agents. The aims of this study were to develop antimonial drugs entrapped into phosphatidylserine liposomes and to analyze their biological and physicochemical characteristics. METHODS: Liposomes containing meglumine antimoniate (MA) or pentavalent antimony salt (Sb) were obtained through filter extrusion (FEL) and characterized by transmission electron microscopy. Promastigotes of Leishmania infantum were incubated with the drugs and the viability was determined with a tetrazolium dye (MTT assay). The effects of these drugs against intracellular amastigotes were also evaluated by optical microscopy, and mammalian cytotoxicity was determined by an MTT assay. RESULTS: Liposomes had an average diameter of 162nm. MA-FEL showed inhibitory activity against intracellular L. infantum amastigotes, with a 50% inhibitory concentration (IC50) of 0.9μg/mL, whereas that of MA was 60μg/mL. Sb-FEL showed an IC50 value of 0.2μg/mL, whereas that of free Sb was 9μg/mL. MA-FEL and Sb-FEL had strong in vitro activity that was 63-fold and 39-fold more effective than their respective free drugs. MA-FEL tested at a ten-times higher concentration than Sb-FEL did not show cytotoxicity to mammalian cells, resulting in a higher selectivity index. CONCLUSIONS: Antimonial drug-containing liposomes are more effective against Leishmania-infected macrophages than the non-liposomal drugs.


Assuntos
Animais , Compostos Organometálicos/farmacologia , Fosfatidilserinas/farmacologia , Macrófagos Peritoneais/parasitologia , Leishmania infantum/efeitos dos fármacos , Gluconato de Antimônio e Sódio/farmacologia , Meglumina/farmacologia , Antiprotozoários/farmacologia , Compostos Organometálicos/química , Fosfatidilserinas/química , Cricetinae , Gluconato de Antimônio e Sódio/química , Concentração Inibidora 50 , Testes de Sensibilidade Parasitária , Relação Dose-Resposta a Droga , Antimoniato de Meglumina , Lipossomos , Meglumina/química , Camundongos , Camundongos Endogâmicos BALB C , Antiprotozoários/química
2.
Acta physiol. pharmacol. ther. latinoam ; 42(3): 183-96, 1992. tab, graf
Artigo em Inglês | LILACS | ID: lil-134661

RESUMO

Cytosol (C) (100,000 x g/60 min, supernatant) from liver, brain and testis (Wistar male rats) are shown to contain insulin degrading activity (C-IDA). The regulation of C-IDA in these fractions by ligands that activate G protein and PKC were examined C-IDA from liver, brain and testis was inhibited 76%; 64% and 50% by 50 mM F- respectively. Chromatography of C fraction from liver on Sephadex G-50 in presence of 1 M (NH4)2SO4 and 20% (v/v) glycerol (experimental condition to remove guanine nucleotides from G proteins) decreased in about 3-fold aluminum fluoride effect on C-IDA. Mg++ (from 5mM to 10 mM) enhanced fluoride effects by inhibiting fully C-IDA. Phosphatidylserine in presence of ATP completely inhibited C-IDA; this inhibition was 31.3% mediated by a phosphorylation reaction. It is concluded that cytosol from different tissues contain proteins capable to associate ligands as aluminum fluoride and PS to regulate C-IDA. It is proposed a mechanism of protein-protein interaction to modulate C-IDA


Assuntos
Animais , Masculino , Citosol/metabolismo , Fluoretos/farmacologia , Técnicas In Vitro , Insulina/metabolismo , Fosfatidilserinas/farmacologia , Trifosfato de Adenosina/farmacologia , Sulfato de Amônio/farmacologia , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Citosol/efeitos dos fármacos , Depressão Química , Proteínas de Ligação ao GTP/metabolismo , Radioisótopos do Iodo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Magnésio/farmacologia , Proteína Quinase C/metabolismo , Ratos , Ratos Wistar , Suínos , Testículo/efeitos dos fármacos , Testículo/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA